China’s clinical drug trial registrations exceed the U.S.’s, causing concerns| SAMR releases national standards for AI agent interconnection to establish a unified identity framework | CATL to work with U.K.-based Octopus Energy to launch battery-swapping stations in Europe
Chinese companies are abandoning their red-chip structures after the Manus case | Trip.com fined for failing to comply with cross-border data security rules, signifying strict enforcement| China's win in Innoscience patent case against Germany's Infineon doesn't necessarily mean continued victory over the German chip giant.
New law extends Beijing’s powers to restrict cross-border dealmaking, hindering biotech deals | Foreign fashion brands could run afoul of China's new supply chain security law | EU scrutinizes Chinese investments in Ferretti and JD.com deals
Beijing court draws clear regulatory distinction between de-identified and anonymous data | Chinese LED chipmaker withdraws $239 million bid for Dutch firm after CFIUS cites U.S. national security risks | Spain’s embrace of proposed Chinese investment raises wider concerns about Chinese investment in Europe
In 2025, there was continuity and change in U.S. policy that impacted both Chinese and APAC investment into the U.S., and U.S. investment into China. For the investment community, a key question has become how to navigate the U.S. regulatory environment while maximizing business opportunities in the two jurisdictions. A U.S. corporate and regulatory lawyer at a U.S. firm helps make sense of the developments
Chinese financial regulator considers allowing major investors to hold stakes in additional banks to boost capital. | Brazilian preliminary injunction bans Geely from patent dispute-related activities. | Envisioned U.S. national AI framework could put pressure on Chinese AI services.
In 2025, China's antitrust landscape continued to evolve with greater sophistication across legislation, merger control, administrative enforcement, and litigation. Here, Huang Wei, Zhu Fan, Gao Chang and Chen Kexin of Tian Yuan Law Firm give an overview of the major developments and key takeaways
China increases scrutiny of Manus-Meta Deal | Recent Chinese notice raises concerns over red-chip company ban in Hong Kong listings | Chinese court rejects circular reuse defense in luxury handbag repurposing dispute
China intensifies efforts to encourage reporting of overseas income | CSRC considers RMB 30 billion market cap floor for H-share listings | Sony to spin off TV business as a joint venture with China’s TCL.
Beijing court established legal framework for trial of fake AI precedent submission in the judgment | China may require asset sales to approve proposed Rio Tinto-Glencore merger | Defu Technology abandons $200 million acquisition after Luxembourg's compulsory investment review imposed minority stake restrictions
